Hesperidin induces apoptosis by inhibiting Sp1 and its regulatory protein in MSTO-211H cells

Biomolecules and Therapeutics

Volumn 20, Issue 3, 2012, Pages 273-279

  Lee, Kyung Ae ^a   Lee, Sang Han ^a   Lee, Yong Jin ^a   Baeg, Seung Mi ^a   Shim, Jung Hyun ^a  

^a Soonchunhyang University   (South Korea)

Author keywords

Hepatitis A virus; Recombinant chimera protein; Rotavirus

Indexed keywords

CASPASE 3; CYCLIN D1; HESPERIDIN; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 2; PROTEIN BAX; PROTEIN BCL X; PROTEIN BID; PROTEIN MCL 1; PROTEIN P21; PROTEIN P27; SURVIVIN; TRANSCRIPTION FACTOR SP1;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; DRUG STRUCTURE; GROWTH INHIBITION; HUMAN; HUMAN CELL; IC 50; MESOTHELIOMA; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; UPREGULATION;

EID: 84862654707     PISSN: 19769148     EISSN: 20054483     Source Type: Journal    
DOI: 10.4062/biomolther.2012.20.3.273     Document Type: Article

References (40)

1. Akiyama, S., Katsumata, S., Suzuki, K., Ishimi, Y., Wu, J. and Uehara, M. (2010) Dietary hesperidin exerts hypoglycemic and hypolipidemic effects in streptozotocin-induced marginal type 1 diabetic rats. J. Clin. Biochem. Nutr. 46, 87-92.
2. Ameer, B., Weintraub, R. A., Johnson, J. V., Yost, R. A. and Rouseff, R. L. (1996) Flavanone absorption after naringin, hesperidin, and citrus administration. Clin. Pharmacol. Ther. 60, 34-40.
3. Carbone, M., Kratzke, R. A. and Testa, J. R. (2002) The pathogenesis of mesothelioma. Semin. Oncol. 29, 2-17.
4. Choi, E. J. (2007) Hesperetin induced G1-phase cell cycle arrest in human breast cancer MCF-7 cells: involvement of CDK4 and p21. Nutr. Cancer 59, 115-119.
5. Chuang, J. Y., Wu, C. H., Lai, M. D., Chang, W. C. and Hung, J. J. (2009) Overexpression of Sp1 leads to p53-dependent apoptosis in cancer cells. Int. J. Cancer 125, 2066-2076.
6. Davie, J. R., He, S., Li, L., Sekhavat, A., Espino, P., Drobic, B., Dunn, K. L., Sun, J. M., Chen, H. Y., Yu, J., Pritchard, S. and Wang, X. (2008) Nuclear organization and chromatin dynamics--Sp1, Sp3 and histone deacetylases. Adv. Enzyme Regul. 48, 189-208.
7. Dimmock, J. R., Elias, D. W., Beazely, M. A. and Kandepu, N. M. (1999) Bioactivities of chalcones. Curr. Med. Chem. 6, 1125-1149.
8. Fresco, P., Borges, F., Diniz, C. and Marques, M. P. (2006) New insights on the anticancer properties of dietary polyphenols. Med. Res. Rev. 26, 747-766.
9. Fresco, P., Borges, F., Marques, M. P. and Diniz, C. (2010) The anticancer properties of dietary polyphenols and its relation with apoptosis. Curr. Pharm. Des. 16, 114-134.
10. Garg, A., Garg, S., Zaneveld, L. J. and Singla, A. K. (2001) Chemistry and pharmacology of the Citrus bioflavonoid hesperidin. Phytother. Res. 15, 655-669.
11. Ghorbani, A., Nazari, M., Jeddi-Tehrani, M. and Zand, H. (2012) The citrus flavonoid hesperidin induces p53 and inhibits NF-κB activation in order to trigger apoptosis in NALM-6 cells: involvement of PPARγ-dependent mechanism. Eur. J. Nutr. 51, 39-46.
12. Horváthová, K., Vachálková, A. and Novotný, L. (2001) Flavonoids as chemoprotective agents in civilization diseases. Neoplasma 48, 435-441.
13. Howells, L. M., Britton, R. G., Mazzoletti, M., Greaves, P., Broggini, M., Brown, K., Steward, W. P., Gescher, A. J. and Sale, S. (2010) Preclinical colorectal cancer chemopreventive effi cacy and p53-modulating activity of 3',4',5'-trimethoxyfl avonol, a quercetin analogue. Cancer Prev. Res (Phila). 3, 929-939.
14. Justesen, U., Knuthsen, P. and Leth, T. (1998) Quantitative analysis of fl avonols, fl avones, and fl avanones in fruits, vegetables and beverages by high-performance liquid chromatography with photo-diode array and mass spectrometric detection. J. Chromatogr. A 799, 101-110.
15. Kamaraj, S., Anandakumar, P., Jagan, S., Ramakrishnan, G. and Devaki, T. (2011) Hesperidin attenuates mitochondrial dysfunction during benzo(a)pyrene-induced lung carcinogenesis in mice. Fundam. Clin. Pharmacol. 25, 91-98.
16. Kanai, M., Imaizumi, A., Otsuka, Y., Sasaki, H., Hashiguchi, M., Tsujiko, K., Matsumoto, S., Ishiguro, H. and Chiba, T. (2011) Doseescalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers. Cancer Chemother. Pharmacol. 69, 65-70.
17. Knekt, P., Kumpulainen, J., Järvinen, R., Rissanen, H., Heliövaara, M., Reunanen, A., Hakulinen, T. and Aromaa, A. (2002) Flavonoid intake and risk of chronic diseases. Am. J. Clin. Nutr. 76, 560-568.
18. Kong, L. M., Liao, C. G., Fei, F., Guo, X., Xing, J. L. and Chen, Z. N. (2010) Transcription factor Sp1 regulates expression of cancerassociated molecule CD147 in human lung cancer. Cancer Sci. 101, 1463-1470.
19. la Porte, C., Voduc, N., Zhang, G., Seguin, I., Tardiff, D., Singhal, N. and Cameron, D. W. (2010) Steady-State pharmacokinetics and tolerability of trans-resveratrol 2000 mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects. Clin. Pharmacokinet. 49, 449-454.
20. Lee, K. H., Yeh, M. H., Kao, S. T., Hung, C. M., Liu, C. J., Huang, Y. Y. and Yeh, C. C. (2010) The inhibitory effect of hesperidin on tumor cell invasiveness occurs via suppression of activator protein 1 and nuclear factor-kappaB in human hepatocellular carcinoma cells. Toxicol. Lett. 194, 42-49.
21. Lee, Y. R., Jung, J. H. and Kim, H. S. (2011) Hesperidin partially restores impaired immune and nutritional function in irradiated mice. J. Med. Food 14, 475-482.
22. Li, L. and Davie, J. R. (2010) The role of Sp1 and Sp3 in normal and cancer cell biology. Ann. Anat. 192, 275-283.
23. Li, Y., Fang, H. and Xu, W. (2007) Recent advance in the research offl avonoids as anticancer agents. Mini. Rev. Med. Chem. 7, 663-678.
24. Neergheen, V. S., Bahorun, T., Taylor, E. W., Jen, L. S. and Aruoma, O. I. (2009) Targeting specifi c cell signaling transduction pathways by dietary and medicinal phytochemicals in cancer chemoprevention. Toxicology 278, 229-241.
25. Nielsen, S. E., Freese, R., Kleemola, P. and Mutanen, M. (2002) Flavonoids in human urine as biomarkers for intake of fruits and vegetables. Cancer Epidemiol. Biomarkers. Prev. 11, 459-466.
26. Park, H. J., Kim, M. J., Ha, E. and Chung, J. H. (2008) Apoptotic effect of hesperidin through caspase3 activation in human colon cancer cells, SNU-C4. Phytomedicine 15, 147-151.
27. Preston, R. K., Avakian, S., Beiler, J. M., Moss, J. N. and Martin, G. J. (1953) In vivo and in vitro inhibition of hyaluronidase by organic phosphates. Exp. Med. Surg. 11, 1-8.
28. Raja, S., Murthy, S. C. and Mason, D. P. (2011) Malignant pleural mesothelioma. Curr. Oncol. Rep. 13, 259-264.
29. Ramos, S. (2008) Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways. Mol. Nutr. Food Res. 52, 507-526.
30. Ren, W., Qiao, Z., Wang, H., Zhu, L. and Zhang, L. (2003) Flavonoids: promising anticancer agents. Med. Res. Rev. 23, 519-534.
31. Robinson, B. W. and Lake, R. A. (2005) Advances in malignant mesothelioma. N. Engl. J. Med. 353, 1591-1603.
32. Safe, S. and Abdelrahim, M. (2005) Sp transcription factor family and its role in cancer. Eur. J. Cancer 41, 2438-2448.
33. Sankpal, U. T., Goodison, S., Abdelrahim, M. and Basha, R. (2011) Targeting Sp1 transcription factors in prostate cancer therapy. Med. Chem. 7, 518-525.
34. Shanafelt, T. D., Call, T. G., Zent, C. S., LaPlant, B., Bowen, D. A., Roos, M., Secreto, C. R., Ghosh, A. K., Kabat, B. F., Lee, M. J., Yang, C. S., Jelinek D. F., Erlichman, C. and Kay, N. E. (2009) Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia. J. Clin. Oncol. 27, 3808-3814.
35. Takigawa, N., Kiura, K. and Kishimoto, T. (2011) Medical treatment of mesothelioma: anything new? Curr. Oncol. Rep. 13, 265-271.
36. Tanaka, T., Makita, H., Kawabata, K., Mori, H., Kakumoto, M., Satoh, K., Hara, A., Sumida, T., Tanaka, T. and Ogawa, H. (1997) Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring fl avonoids, diosmin and hesperidin. Carcinogenesis 18, 957-965.
37. Tsuda, H., Ohshima, Y., Nomoto, H., Fujita, K., Matsuda, E., Iigo, M., Takasuka, N. and Moore, M. A. (2004) Cancer prevention by natural compounds. Drug Metab. Pharmacokinet. 19, 245-263.
38. Yang, M., Tanaka, T., Hirose, Y., Deguchi, T., Mori, H. and Kawada, Y. (1997) Chemopreventive effects of diosmin and hesperidin on Nbutyl-N-(4-hydroxybutyl)nitrosamine-induced urinary-bladder carcinogenesis in male ICR mice. Int. J. Cancer 73, 719-724.
39. Yeh, M. H., Kao, S. T., Hung, C. M., Liu, C. J., Lee, K. H. and Yeh, C. C. (2009) Hesperidin inhibited acetaldehyde-induced matrix metalloproteinase-9 gene expression in human hepatocellular carcinoma cells. Toxicol. Lett. 184, 204-210.
40. Zucali, P. A., Ceresoli, G. L., De Vincenzo, F., Simonelli, M., Lorenzi, E., Gianoncelli, L. and Santoro, A. (2011) Advances in the biology of malignant pleural mesothelioma. Cancer Treat. Rev. 37, 543-558.